Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U0LH
|
||||
Former ID |
DNC003627
|
||||
Drug Name |
18-Dimethylaminocoronaridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C23H31N3O2
|
||||
Canonical SMILES |
CN(C)CCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC
|
||||
InChI |
1S/C23H31N3O2/c1-25(2)10-8-16-12-15-13-23(22(27)28-3)20-18(9-11-26(14-15)21(16)23)17-6-4-5-7-19(17)24-20/h4-7,15-16,21,24H,8-14H2,1-3H3/t15?,16-,21-,23+/m0/s1
|
||||
InChIKey |
WUYGHHRQOSQDIC-NVVKDKPXSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Neuronal acetylcholine receptor protein, beta-4 chain | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Nicotinic acetylcholine receptor signaling pathway | ||||
Nicotine pharmacodynamics pathway | |||||
Reactome | Highly sodium permeable acetylcholine nicotinic receptors | ||||
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | |||||
Highly calcium permeable nicotinic acetylcholine receptors | |||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||||
Nicotine Activity on Chromaffin Cells | |||||
References | |||||
REF 1 | J Med Chem. 2003 Jun 19;46(13):2716-30.Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.